Secondary Metabolites of Onygenales Fungi Exemplified by Aioliomyces pyridodomos.


Journal

Journal of natural products
ISSN: 1520-6025
Titre abrégé: J Nat Prod
Pays: United States
ID NLM: 7906882

Informations de publication

Date de publication:
28 06 2019
Historique:
pubmed: 4 6 2019
medline: 15 9 2020
entrez: 4 6 2019
Statut: ppublish

Résumé

Fungi from the order Onygenales include human pathogens. Although secondary metabolites are critical for pathogenic interactions, relatively little is known about Onygenales compounds. Here, we use chemical and genetic methods on Aioliomyces pyridodomos, the first representative of a candidate new family within Onygenales. We isolated 14 new bioactive metabolites, nine of which are first disclosed here. Thirty-two specialized metabolite biosynthetic gene clusters (BGCs) were identified. BGCs were correlated to some of the new compounds by heterologous expression of biosynthetic genes. Some of the compounds were found after one year of fermentation. By comparing BGCs from A. pyridodomos with those from 68 previously sequenced Onygenales fungi, we delineate a large biosynthetic potential. Most of these biosynthetic pathways are specific to Onygenales fungi and have not been found elsewhere. Family level specificity and conservation of biosynthetic gene content are evident within Onygenales. Identification of these compounds may be important to understanding pathogenic interactions.

Identifiants

pubmed: 31155876
doi: 10.1021/acs.jnatprod.9b00121
pmc: PMC7093054
mid: NIHMS1554560
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1616-1626

Subventions

Organisme : NIAID NIH HHS
ID : R00 AI112691
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137418
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM107557
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM122521
Pays : United States

Références

J Antibiot (Tokyo). 2009 Apr;62(4):217-9
pubmed: 19218980
J Mol Biol. 2000 Sep 8;302(1):205-17
pubmed: 10964570
Eur J Med Chem. 2016 Jan 27;108:229-244
pubmed: 26686929
J Org Chem. 2012 Nov 16;77(22):9933-53
pubmed: 22938194
Genome Res. 2009 Oct;19(10):1722-31
pubmed: 19717792
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Bioorg Med Chem. 2015 Feb 15;23(4):712-9
pubmed: 25600409
Org Lett. 2014 Sep 19;16(18):4774-7
pubmed: 25188821
Cell. 2014 Jul 17;158(2):412-421
pubmed: 25036635
J Org Chem. 1997 Oct 17;62(21):7512-7515
pubmed: 11671879
G3 (Bethesda). 2015 Nov 27;6(2):235-44
pubmed: 26613950
Chembiochem. 2013 Jan 2;14(1):28-42
pubmed: 23225733
J Antibiot (Tokyo). 2018 Feb;71(2):339-341
pubmed: 28588225
Nucleic Acids Res. 2014 Jan;42(Database issue):D206-14
pubmed: 24293654
J Antibiot (Tokyo). 2014 Aug;67(8):585-8
pubmed: 24802211
PLoS Genet. 2011 Oct;7(10):e1002345
pubmed: 22046142
Bioinformatics. 2008 Mar 1;24(5):637-44
pubmed: 18218656
Sci Rep. 2015 Feb 10;5:8365
pubmed: 25666585
J Nat Prod. 2018 Dec 28;81(12):2605-2611
pubmed: 30507122
Neurosci Bull. 2018 Feb;34(1):120-142
pubmed: 29282613
Annu Rev Microbiol. 2004;58:453-88
pubmed: 15487945
Front Immunol. 2018 Nov 06;9:2549
pubmed: 30459771
BMC Genomics. 2008 Feb 08;9:75
pubmed: 18261238
mBio. 2012 Sep 04;3(5):e00259-12
pubmed: 22951933
PLoS Pathog. 2008 Apr 11;4(4):e1000044
pubmed: 18404210
Org Lett. 2006 Oct 26;8(22):5169-71
pubmed: 17048870
Biochem Biophys Res Commun. 1968 Aug 21;32(4):664-71
pubmed: 5682289
Bioinformatics. 2012 Jun 1;28(11):1420-8
pubmed: 22495754
J Nat Prod. 1995 Dec;58(12):1983-6
pubmed: 8691217
Med Mycol. 2011 Aug;49(6):633-42
pubmed: 21341981
ACS Synth Biol. 2013 Nov 15;2(11):629-34
pubmed: 23758576
Methods Mol Biol. 2017;1520:23-47
pubmed: 27873244
Mol Biol Evol. 2013 May;30(5):1218-23
pubmed: 23412913
Bioinformatics. 2009 Aug 1;25(15):1972-3
pubmed: 19505945
Nat Microbiol. 2017 Apr 03;2:17044
pubmed: 28368369
Genome Biol. 2011;12(1):R7
pubmed: 21247460
J Am Chem Soc. 2017 Jul 26;139(29):9807-9810
pubmed: 28683547
J Antibiot (Tokyo). 1988 Dec;41(12):1785-94
pubmed: 3209473
Sci Adv. 2018 Apr 11;4(4):eaar5459
pubmed: 29651464
Phytochemistry. 2005 Dec;66(23):2776-9
pubmed: 16213536
FEMS Microbiol Lett. 2011 Jul;320(2):79-86
pubmed: 21457342
Nucleic Acids Res. 2017 Jul 3;45(W1):W36-W41
pubmed: 28460038
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
ACS Synth Biol. 2015 May 15;4(5):625-33
pubmed: 25226362
ISME J. 2015 Mar;9(3):615-28
pubmed: 25171330
Annu Rev Genet. 2016 Nov 23;50:371-392
pubmed: 27732794

Auteurs

Zhenjian Lin (Z)

Department of Medicinal Chemistry , University of Utah , Salt Lake City , Utah 84112 , United States.

Thomas B Kakule (TB)

Department of Medicinal Chemistry , University of Utah , Salt Lake City , Utah 84112 , United States.

Christopher A Reilly (CA)

Department of Pharmacology & Toxicology and Center for Human Toxicology , University of Utah , Salt Lake City , Utah 84112 , United States.

Sinem Beyhan (S)

Department of Infectious Diseases , J. Craig Venter Institute , La Jolla , California 92037 , United States.
Department of Medicine , University of California, San Diego , La Jolla , California 92093 , United States.

Eric W Schmidt (EW)

Department of Medicinal Chemistry , University of Utah , Salt Lake City , Utah 84112 , United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH